429 related articles for article (PubMed ID: 15301575)
1. Clinical pharmacokinetics of levetiracetam.
Patsalos PN
Clin Pharmacokinet; 2004; 43(11):707-24. PubMed ID: 15301575
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetic characteristics of levetiracetam.
Patsalos PN
Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):123-9. PubMed ID: 12731458
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
Dooley M; Plosker GL
Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
[TBL] [Abstract][Full Text] [Related]
5. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
Patsalos PN
Pharmacol Ther; 2000 Feb; 85(2):77-85. PubMed ID: 10722121
[TBL] [Abstract][Full Text] [Related]
7. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of levetiracetam in Japanese and Western adults.
Pigeolet E; Jacqmin P; Sargentini-Maier ML; Stockis A
Clin Pharmacokinet; 2007; 46(6):503-12. PubMed ID: 17518509
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers.
Strolin Benedetti M; Whomsley R; Nicolas JM; Young C; Baltes E
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):621-30. PubMed ID: 14530892
[TBL] [Abstract][Full Text] [Related]
11. Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
Patsalos PN
Epilepsia; 2005; 46 Suppl 9():140-8. PubMed ID: 16302888
[TBL] [Abstract][Full Text] [Related]
12. Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.
Stockis A; Sargentini-Maier ML; Otoul C; Connor A; Wilding I; Wray H
Clin Ther; 2010 Sep; 32(10):1813-21. PubMed ID: 21194605
[TBL] [Abstract][Full Text] [Related]
13. Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials.
Perucca E; Gidal BE; Baltès E
Epilepsy Res; 2003 Feb; 53(1-2):47-56. PubMed ID: 12576167
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
Coupez R; Nicolas JM; Browne TR
Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570
[TBL] [Abstract][Full Text] [Related]
15. An assessment of levetiracetam as an anti-epileptic drug.
Jain KK
Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
[TBL] [Abstract][Full Text] [Related]
17. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam.
Nash EM; Sangha KS
Am J Health Syst Pharm; 2001 Jul; 58(13):1195-9. PubMed ID: 11449876
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of oxcarbazepine.
May TW; Korn-Merker E; Rambeck B
Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam: a novel antiepileptic drug.
Hovinga CA
Pharmacotherapy; 2001 Nov; 21(11):1375-88. PubMed ID: 11714211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
